HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinogenicity in rats of the nitrosourea amino acid N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine.

Abstract
The carcinogenicity of the nitrosourea amino acid, N delta-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO), and its acute cytotoxicity were studied in Wistar rats. MNCO treatment induced a high incidence of neoplasms in breast, kidney, and skin and a lower incidence of tumors in the exocrine pancreas and ear duct. The duration of these studies was limited by toxicity and carcinogenicity to six months in a high dose group which received 1 mmole MNCO/kg IP weekly for 6 months and to 1 year in a group which received 0.33 mmole/kg. In the latter group the incidence of neoplasms was breast, 40%; skin, 52%; kidney, 81%; pancreas, 19%; and ear duct, 4%. All pancreases in this group also contained foci of fibrosis and cyst formation, and atypical acinar cell nodules. Acute cytotoxic effects were noted in pancreas, kidney and skin after a single IP injection of 3 mmoles/kg although this dose caused no deaths acutely.
AuthorsD S Longnecker, T J Curphey, H S Lilja, J I French, D S Daniel
JournalJournal of environmental pathology and toxicology (J Environ Pathol Toxicol) Vol. 4 Issue 1 Pg. 117-29 (Aug 1980) ISSN: 0146-4779 [Print] United States
PMID7441106 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carcinogens
  • Nitrosourea Compounds
  • N(delta)-(N-methyl-N-nitrosocarbamoyl)-L-ornithine
  • Ornithine
Topics
  • Animals
  • Body Weight (drug effects)
  • Carcinogens (metabolism)
  • Female
  • Male
  • Neoplasms, Experimental (chemically induced, pathology)
  • Nitrosourea Compounds (metabolism, toxicity)
  • Ornithine (analogs & derivatives, metabolism, toxicity)
  • Pancreatic Neoplasms (chemically induced)
  • Rats
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: